« Previous
Next »
Journal of the American Academy of Dermatology
Volume 59, Issue 3
, Pages 397-404.e3
, September 2008
Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women
References
- Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocrinology. 1997;138:863–870
- . Demonstration of estrogen receptors in the skin. J Endocrinol Invest. 1980;3:217–221
- . Sequence and expression of human estrogen receptor complementary DNA. Science. 1986;231:1150–1154
- . Does hormonal skin aging exist?. Dermatology. 1996;193:289–294
- . Skin aging and menopause. Am J Clin Dermatol. 2003;4:371–378
- . Does estrogen prevent skin aging? Results from the First National and Health Nutritional Examination Survey. Arch Dermatol. 1997;133:339–342
- A randomized, double-blind, placebo controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994;170:642–649
- . Skin water-holding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas. 1995;22:151–154
- . Effect of a conjugated oestrogen (Premarin) cream on aging facial skin. A comparative study with a placebo cream. Maturitas. 1994;19:211–223
- . Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155:1137–1146
- Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas. 1999;33:239–247
- Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynecol. 1985;92:256–259
- Effects of hormone replacement therapy on skin biophysical properties of postmenopausal women. Skin Res Technol. 2005;11:201–204
- . Short term effects of topical 17 Beta estradiol on human post menopausal skin. Maturitas. 1989;11:229–234
- . Skin changes in menopause Maturitas. 1989;11:295–304
- Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas. 1997;27:153–162
- . Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol. 1987;70:123–127
- Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA. 2004;292:1581–1587
- . Response of skin thickness and metacarpal index to estradiol therapy in postmenopausal women. Obstet Gynecol. 1987;70:538–541
- Decline in skin collagen content and metacarpal index after the menopause and its prevention with sex hormone replacement. Br J Obstet Gynecol. 1987;94:126–129
- . Sex hormones and skin collagen content in postmenopausal women. Br Med J Clin Res. 1983;287:1337–1338
- Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas. 1987;9:1–5
- . Estrogen deficiency. In: Riggs BL, Melton LJ editor. Osteoporosis: etiology, diagnosis, and management. Philadelphia: Lippincott-Raven; 1995;p. 137
- . Facial wrinkling in postmenopausal women. Effects of smoking status and hormone replacement therapy. Maturitas. 1998;29:75–86
- . Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women. Ann Chir Gynaecol Suppl. 1987;202:39–41
- The effect of topical oestradiol on skin collagen of postmenopausal women. Br J Obstet Gynaecol. 1995;102:985–989
- . Age-related changes in facial skin contours and rheology. J Am Geriatr Soc. 1997;45:220–222
- . The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynecol Obstet. 2000;68:35–41
- Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;207:1465–1477
Supported by a grant from Pfizer, Inc.
Disclosure: Dr Symons was employed in the Clinical Research Department at Pfizer Inc at the time this study was conducted. He was a member of the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, when the manuscript was written. Dr Phillips is on the Scientific Advisory Board of Hygeia Therapeutics.
Reprints not available from the authors.
PII: S0190-9622(08)00595-1
doi: 10.1016/j.jaad.2008.05.009
© 2008 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Journal of the American Academy of Dermatology
Volume 59, Issue 3
, Pages 397-404.e3
, September 2008
